EP Biocomposites

Has EP Biocomposites declared dividend?

No Dividend History Available

What is the technical trend for EP Biocomposites?

As of June 4, 2025, EP Biocomposites exhibits a mildly bearish technical trend, influenced by bearish moving averages and Bollinger Bands, despite mixed signals from the MACD and KST indicators.

As of 4 June 2025, the technical trend for EP Biocomposites has changed from does not qualify to mildly bearish. The weekly MACD indicates a mildly bullish stance, but the monthly MACD is mildly bearish, suggesting mixed signals. The Bollinger Bands and moving averages both show a mildly bearish trend on the weekly and daily time frames. The KST is bearish on the weekly, reinforcing the overall bearish sentiment. The Dow Theory indicates a mildly bearish trend on the weekly, with no trend on the monthly. Overall, the current technical stance is mildly bearish, driven primarily by the moving averages and Bollinger Bands.

Who are the peers of the EP Biocomposites?

EP Biocomposites' peers include Antony Waste, Eco Recyc, Concord Enviro, and others, with varying management and growth risks. Notably, EP Biocomposites has a 1-year return of -35.14%, better than Gem Enviro's -77.16% but worse than Antony Waste's 6.68%.

Peers: The peers of EP Biocomposites are Antony Waste han, Eco Recyc., Concord Enviro, JITF Infra Logis, Denta Water, VVIP Infratech, Race Eco, Organic Recyclin, Gem Enviro, and Filtra Consult.<BR><BR>Quality Snapshot: Excellent management risk is observed at Eco Recyc., VVIP Infratech, and Gem Enviro, while Good management risk is found at EP Biocomposites, Antony Waste han, and Filtra Consult. Average management risk is present at Denta Water and Concord Enviro, while Below Average management risk is noted at Race Eco and Organic Recyclin. JITF Infra Logis does not qualify for management risk assessment. For growth, Excellent growth is seen at Eco Recyc., VVIP Infratech, and Organic Recyclin, while Good growth is noted at EP Biocomposites. Below Average growth is found at Antony Waste han, Concord Enviro, Denta Water, and Race Eco. JITF Infra Logis does not qualify for growth assessment. In terms of capital structure, Excellent capital structure is observed at Eco Recyc., Concord Enviro, and Gem Enviro, while Good capital structure is noted at EP Biocomposites, Antony Waste han, and Filtra Consult. Below Average capital structure is present at Race Eco and Organic Recyclin.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Antony Waste han at 6.68%, while the peer with the lowest is Gem Enviro at -77.16%. EP Biocomposites has a 1-year return of -35.14%, which is higher than Gem Enviro's return but lower than Antony Waste han's. Additionally, several peers, including JITF Infra Logis, VVIP Infratech, Race Eco, and Gem Enviro, have negative six-month returns.

Who are in the management team of EP Biocomposites?

As of March 2022, the management team of EP Biocomposites includes Rajkumar Kamat (Managing Director), Leena Kamat, Shreyas Nadkarni (Directors), and independent directors Nitin A Kunkolienker and Dinesh Shenoy.

As of March 2022, the management team of EP Biocomposites includes the following individuals:<BR><BR>- Rajkumar Kamat, Managing Director<BR>- Leena Kamat, Director<BR>- Shreyas Nadkarni, Director<BR>- Nitin A Kunkolienker, Independent Director<BR>- Dinesh Shenoy, Independent Director<BR><BR>These individuals make up the board of directors for the company.

What does EP Biocomposites do?

EP Biocomposites Ltd manufactures fibre reinforced polymer products and bio toilet solutions, classified as a Micro Cap company with a market cap of INR 19 Cr. The company was incorporated in 2020 and took over M/s. OM Ventures in 2021, but has not reported recent sales or profit data.

Overview: <BR>EP Biocomposites Ltd is engaged in the manufacture of fibre reinforced polymer products and bio toilet solutions, operating within the Other Utilities industry and classified as a Micro Cap company.<BR><BR>History: <BR>EP Biocomposites Limited was incorporated as a Public Limited Company on January 17, 2020. The company underwent a significant change when it took over the running business of M/s. OM Ventures on August 31, 2021. There is no recent sales or profit data reported.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 19 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 20.00 <BR>Industry P/E: 32 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.06 <BR>Return on Equity: 10.77% <BR>Price to Book: 1.95 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

Who are the top shareholders of the EP Biocomposites?

The top shareholder of EP Biocomposites is Leena Rajkumar Kamat, holding 64.93% of the shares, with no pledged holdings. The highest public shareholder is Sambhav Dawar at 1.04%, while individual investors collectively own 26.41%.

The top shareholders of EP Biocomposites include the promoters, with Leena Rajkumar Kamat holding the largest share at 64.93%. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors (FIIs) holding shares. The highest public shareholder is Sambhav Dawar, who owns 1.04%. Additionally, individual investors collectively hold 26.41% of the shares.

How big is EP Biocomposites?

As of 24th July, EP Biocomposites Ltd has a market capitalization of 22.00 Cr, classifying it as a Micro Cap company, with no available financial data for Net Sales and Net Profit for the latest four quarters. The balance sheet as of March 2024 shows Shareholder's Funds of 9.56 Cr and Total Assets of 15.07 Cr.

As of 24th July, <BR><BR>Market Cap: EP Biocomposites Ltd has a market capitalization of 22.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales and Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2024, with Shareholder's Funds amounting to 9.56 Cr and Total Assets valued at 15.07 Cr.

When is the next results date for EP Biocomposites?

The next results date for EP Biocomposites is November 3, 2025.

The next results date for EP Biocomposites is scheduled for November 3, 2025.

How has been the historical performance of EP Biocomposites?

EP Biocomposites has shown steady growth in net sales and profitability from Mar'21 to Mar'25, with net sales increasing from 2.95 Cr to 12.01 Cr and profit after tax rising from 0.36 Cr to 1.03 Cr, despite fluctuations in raw material costs and stagnant cash flow. Total assets and liabilities also grew significantly during this period.

Answer:<BR>The historical performance of EP Biocomposites shows a progressive increase in net sales and profitability over the years, with notable fluctuations in certain metrics.<BR><BR>Breakdown:<BR>EP Biocomposites has demonstrated a steady growth in net sales, rising from 2.95 Cr in Mar'21 to 12.01 Cr in Mar'25. The total operating income followed a similar trend, increasing from 2.95 Cr in Mar'21 to 12.01 Cr in Mar'25. However, the raw material costs also escalated, reaching 7.98 Cr in Mar'25 from 1.79 Cr in Mar'21. Operating profit, excluding other income, improved from 0.46 Cr in Mar'21 to 1.78 Cr in Mar'25, while the overall operating profit, including other income, increased from 0.46 Cr to 1.89 Cr in the same period. Profit before tax peaked at 1.42 Cr in Mar'25, although it slightly declined from 1.57 Cr in Mar'24. Profit after tax also saw growth, reaching 1.03 Cr in Mar'25 compared to 0.36 Cr in Mar'21. The company's total assets increased significantly from 0.55 Cr in Mar'20 to 16.61 Cr in Mar'25, alongside total liabilities which rose from 0.55 Cr to 16.61 Cr. Cash flow from operating activities remained stagnant at 0.00 Cr in Mar'25, while cash and cash equivalents at the end of the period were stable at 1.00 Cr. Overall, EP Biocomposites has shown resilience and growth in its financial performance over the years, despite some fluctuations in profit margins and cash flow.

Is EP Biocomposites overvalued or undervalued?

As of November 19, 2025, EP Biocomposites is considered overvalued with a PE ratio of 15.35, an EV to EBIT of 11.15, and a year-to-date return of -45.03%, significantly underperforming compared to its peers and the Sensex.

As of 19 November 2025, EP Biocomposites has moved from a fair valuation to an expensive rating. The company is currently considered overvalued based on its financial metrics. Key ratios include a PE ratio of 15.35, an EV to EBIT of 11.15, and a ROCE of 12.38%. <BR><BR>In comparison to its peers, EP Biocomposites' PE ratio is significantly lower than that of Altius Telecom, which has a PE of 51.84, indicating that EP Biocomposites is not positioned favorably within its industry. Additionally, the company's recent stock performance has lagged behind the Sensex, with a year-to-date return of -45.03% compared to the Sensex's 9.02%, further reinforcing the notion that the stock is overvalued.

Why is EP Biocomposites Ltd falling/rising?

As of 17-Mar, EP Biocomposites Ltd's stock price is stable at 99.00, with recent short-term gains but a longer-term decline of 4.81% year-to-date and 8.33% over the past year. The stock's performance is hindered by declining investor participation and erratic trading patterns.

As of 17-Mar, EP Biocomposites Ltd's stock price is currently stable at 99.00, showing no change from the previous trading session. However, the stock has experienced a mixed performance over various periods. In the past week, it has risen by 3.12%, significantly outperforming the Sensex, which fell by 2.73%. Over the last month, the stock has also increased by 1.02%, while the Sensex declined by 8.84%. <BR><BR>Despite these recent gains, the year-to-date performance shows a decline of 4.81%, which is better than the Sensex's drop of 10.74%. Over the past year, the stock has decreased by 8.33%, contrasting with the Sensex's increase of 2.56%. The longer-term view is less favorable, with a significant drop of 47.89% over three years compared to a 31.18% rise in the Sensex.<BR><BR>Today's trading performance indicates that the stock outperformed its sector by 0.45%, but there are signs of erratic trading, as it did not trade on two days out of the last twenty. Additionally, there is a concerning trend in investor participation, with delivery volume on March 11 falling by 28.57% against the five-day average. This decline in trading activity could indicate waning investor interest, which may contribute to a lack of upward momentum in the stock price.<BR><BR>Overall, while there are short-term gains, the longer-term performance and declining investor participation suggest that the stock may face challenges in maintaining its current price level.

Why is EP Biocomposites Ltd falling/rising?

As of 18-Mar, the stock price of EP Biocomposites Ltd is stable at 99.00, with a slight outperformance against the Sensex in the short term. However, it has experienced a year-to-date decline of -4.81%, indicating a negative overall trend despite recent resilience.

As of 18-Mar, the stock price of EP Biocomposites Ltd is currently stable at 99.00, showing no change (0.00%). Over the past week, the stock has slightly outperformed the benchmark Sensex, with a decline of only -0.10% compared to the Sensex's -0.21%. However, looking at the longer-term performance, the stock has experienced a year-to-date decline of -4.81%, which is better than the Sensex's -9.99% decline, indicating a relative strength in the short term.<BR><BR>In the past month, the stock has increased by +1.02%, while the Sensex has dropped significantly by -8.40%. This suggests that the stock has been resilient compared to broader market trends. Nevertheless, over the past year, EP Biocomposites Ltd has seen a decline of -5.71%, contrasting with the Sensex's gain of +1.86%. This longer-term perspective shows that while the stock has had some recent positive movement, it has struggled overall.<BR><BR>Additionally, the stock has shown erratic trading patterns, not trading on 2 out of the last 20 days, which may contribute to uncertainty among investors. The delivery volume has also decreased by -28.57% against the 5-day average, indicating falling investor participation. Despite being liquid enough for trading, the stock's moving averages indicate that it is currently lower than the 50-day, 100-day, and 200-day moving averages, which could suggest a bearish trend.<BR><BR>In summary, while EP Biocomposites Ltd has shown some recent resilience and outperformance against the benchmark in the short term, the overall trend remains negative, with significant declines over the longer periods and decreasing investor participation contributing to a cautious outlook.

Why is EP Biocomposites Ltd falling/rising?

As of 19-Mar, EP Biocomposites Ltd's stock price is at 98.00, down -1.01% and underperforming against the Sensex, which has declined -2.40% over the past week. The stock has shown a negative trend year-to-date and over the past year, with significant declines compared to the Sensex, despite a recent increase in investor participation.

As of 19-Mar, EP Biocomposites Ltd's stock price is falling, currently at 98.00, reflecting a change of -1.0 (-1.01%). The stock has underperformed compared to the benchmark Sensex, which has seen a decline of -2.40% over the past week, while EP Biocomposites Ltd has decreased by -1.11%. Over the past month, the stock has also fallen by -0.96%, compared to a more significant drop of -10.05% in the Sensex.<BR><BR>Year-to-date, the stock is down -5.77%, while the Sensex has decreased by -12.92%. However, over the past year, EP Biocomposites Ltd has experienced a more substantial decline of -6.67%, contrasting with the Sensex's slight decrease of -1.65%. The three-year performance shows a stark difference, with the stock down -48.42% compared to the Sensex's gain of +27.97%.<BR><BR>Today's trading performance indicates that the stock has not fluctuated, remaining at the opening price of 98, and has shown erratic trading patterns, not trading on 4 out of the last 20 days. Although the stock has outperformed its sector by 1.13% today, the overall trend remains negative, compounded by the sector's decline of -2.16%. <BR><BR>Despite a rise in investor participation, with a delivery volume increase of 42.86% on March 16, the stock's liquidity remains low, suggesting limited trading activity. The moving averages indicate that while the stock is higher than the 5-day and 20-day averages, it is lower than the 50-day, 100-day, and 200-day averages, further supporting the downward trend.

Why is EP Biocomposites Ltd falling/rising?

As of 20-Mar, EP Biocomposites Ltd's stock price has risen to 102.70, reflecting a 4.8% increase, driven by strong relative performance, increased investor participation, and positive technical indicators. The stock is currently above its short-term moving averages, suggesting positive momentum.

As of 20-Mar, EP Biocomposites Ltd is experiencing a rise in its stock price, currently at 102.70, which reflects an increase of 4.7 or 4.8%. This upward movement is supported by several factors. Firstly, the stock outperformed its sector by 4.68% today, indicating strong relative performance. Additionally, it opened with a gain of 4.8%, reaching an intraday high of Rs 102.7, and has maintained this price throughout the trading session.<BR><BR>Another contributing factor to the stock's rise is the increase in investor participation, as evidenced by a delivery volume of 1,000 shares on 19 March, which represents a 66.67% increase compared to the 5-day average delivery volume. This suggests growing interest and confidence among investors.<BR><BR>Moreover, the stock is currently trading above its 5-day and 20-day moving averages, which can be seen as a positive technical indicator, although it remains below its longer-term moving averages (50-day, 100-day, and 200-day). Overall, these elements combined indicate a positive momentum for EP Biocomposites Ltd, leading to the observed rise in its stock price.

Why is EP Biocomposites Ltd falling/rising?

As of 23-Mar, the stock price of EP Biocomposites Ltd is stable at 102.70, with a positive performance today, outperforming its sector by 4.68%. However, it has a year-to-date decline of 1.25% and a significant drop of 49.71% over the past three years, indicating mixed long-term performance.

As of 23-Mar, the stock price of EP Biocomposites Ltd is currently stable at 102.70, showing no change (0.00%). However, the stock has demonstrated a positive performance today, outperforming its sector by 4.68% and opening with a gain of 4.8%. It reached an intraday high of Rs 102.7, indicating a strong start to the trading day.<BR><BR>In terms of trading activity, there has been a notable increase in investor participation, with delivery volume rising by 66.67% compared to the 5-day average. This suggests a growing interest among investors, which could be contributing to the stock's stability and slight upward movement today.<BR><BR>Despite these positive indicators, the stock has faced challenges over longer periods, with a year-to-date decline of 1.25% and a significant drop of 49.71% over the past three years. Additionally, the stock has not traded on three days out of the last twenty, indicating erratic trading behavior. <BR><BR>Overall, while the stock is currently stable and showing some positive signs today, its longer-term performance has been less favorable, which may affect investor sentiment in the future.

Why is EP Biocomposites Ltd falling/rising?

As of 24-Mar, EP Biocomposites Ltd's stock price is stable at 102.70, with a recent positive performance trend, outperforming its sector by 4.68%. Despite a year-to-date decline, the stock shows potential for recovery due to increased investor participation and recent gains.

As of 24-Mar, EP Biocomposites Ltd's stock price is currently stable at 102.70, showing no change (0.00%). However, the stock has demonstrated a positive performance trend recently, outperforming its sector by 4.68% today. It opened with a gain of 4.8%, reaching an intraday high of Rs 102.7. This indicates a strong start to the trading day.<BR><BR>In the past week, the stock has increased by 3.74%, while the benchmark Sensex has declined by 2.63%. Over the last month, the stock has also risen by 2.75, contrasting with a significant drop of 9.92% in the Sensex. Despite a year-to-date decline of 1.25%, the stock's recent performance suggests a potential recovery, especially with rising investor participation, as evidenced by a 66.67% increase in delivery volume compared to the 5-day average.<BR><BR>While the stock is currently trading at the same price it opened, it is above the 5-day and 20-day moving averages, which may indicate a short-term upward trend. However, it remains below the longer-term moving averages (50-day, 100-day, and 200-day), suggesting that while there is some positive momentum, the stock has not yet regained its longer-term strength.<BR><BR>Overall, the combination of recent gains, improved trading activity, and outperformance against the sector contributes to the perception of a rising stock, despite its current price stability.

Why is EP Biocomposites Ltd falling/rising?

As of 25-Mar, EP Biocomposites Ltd's stock price is rising to 107.90, up 5.2 (5.06%), driven by strong performance against the Sensex and positive investor sentiment, despite a decline in delivery volume. The stock has shown stability and outperformed its sector, indicating continued interest.

As of 25-Mar, EP Biocomposites Ltd's stock price is rising, currently at 107.90, reflecting a change of 5.2 (5.06%) upward. This increase is supported by several factors. Over the past week, the stock has outperformed the benchmark Sensex, gaining 8.99% while the Sensex declined by 1.87%. Additionally, the stock has shown a positive performance over the past month with a rise of 7.95%, contrasting with the Sensex's drop of 8.51%.<BR><BR>Today's trading activity indicates a strong start, as the stock opened with a gain of 5.06% and reached an intraday high of Rs 107.9. Furthermore, it has consistently traded at this price without any fluctuations, suggesting stability in the current price level. The stock's performance today has outpaced its sector by 3.52%, indicating positive investor sentiment.<BR><BR>However, it is worth noting that there has been a decline in investor participation, with delivery volume dropping by 28.57% compared to the 5-day average. Despite this, the stock remains liquid enough for trading, based on its average traded value. Overall, the combination of recent gains, positive performance relative to the benchmark, and a strong opening today contributes to the rising stock price of EP Biocomposites Ltd.

Which are the latest news on EP Biocomposites?